I obtained my PhD in biochemistry in 2000. My first postdoctoral position was in a hypertension lab working on the mineralocorticoid receptor. In this lab, I was introduced to nuclear receptor biology and physiology. In 2005 I moved to Tulane University in New Orleans to work on another nuclear receptor, the estrogen receptor (ER). Specifically, I was interested in the effects of endocrine disrupting chemicals’ effects on ER biology and what roles these chemicals might play in ER-dependent breast cancer. I was also involved in projects concerning drug resistance in breast cancer and in dissecting molecular mechanisms of drug resistance and triple negative breast cancer. My current work focuses on mutations within the ER that render it constitutively active. I am particularly interested in understanding the mechanisms through which breast cancer cells either acquire these mutations. I believe my previous work elucidating molecular mechanisms of ER crosstalk with cellular pathways gives me a firm foundation to pursue my current work.